Abstract: A space-saving suitcase assembly comprising a plurality of telescoping tubes, the plurality of telescoping tubes including a base tube and a top tube; a handle connected to the top tube; a release button positioned on the handle; the suitcase having a top side, a front side, a back side, a left side, a right side, and a bottom side creating a perimeter surface and an internal volume, a modular stabilizing element made from a rigid material, the modular stabilizing element affixed to the top side via mounting hardware; the base tube connected to the modular stabilizing element providing support to the plurality of telescoping tubes. The modular stabilizing element, the top of the suitcase, or the entire suitcase with modular stabilizing element and base tube and telescoping handles may be manufactured as one unit by injection molding, CNC machining, or 3D additive manufacturing (3D printing), or other manufacturing process.

Abstract: The invention is a device and method to allow a user to minimize wrinkles in the transportation of garments. In a main embodiment, the invention consists of folding folds with a hanging means with two holding bars (or “arms”), one over the connecting area between the top fold and middle fold, and one over the connecting area between the middle fold and the bottom fold, with a top and bottom edge where clothes are attached to said device through the use of flexible clips with a tension means. Alternative embodiments, and suitcase structure change, are described to decrease wrinkling, and increase available volume within suitcases. The device is designed to be folded and contained with a standard suitcase, or is built in as part of a suitcase.

Abstract: The invention is a patch or other applicator, or other method of administration, and a process to concept is to utilize patches (or other methods of delivery), that may contain nicotine in addition to, and that contain other chemicals that have been shown, or will be shown, either by subjective or objective measures, to increase “impact” (an tobacco industry term for the subjective awareness by the smoker of the drug effects of nicotine), or to increase addiction. Chemicals that decrease addiction behavior, or decrease signs and symptoms of withdrawal from the addictive substance or behavior may also be included. The claimed methods have application in the treatment of addiction to tobacco products, addiction to alcohol, and other addictions.

Abstract: The present invention is a novel method for medication treatment for Alzheimer's Disease, Mild Cognitive Impairment, Age Associated Memory Impairment, other disorders with memory impairment, and for possible treatment strategies for memory improvement.

Abstract: This invention relates to a method for significantly increasing the accuracy of predicting and selecting an antidepressant agent, or other pharmacological agent for treatment of a disease state, that will be effective based on pre-treatment or baseline, placebo treatment and/or active treatment, or other post-treatment time period data, early changes quantitative EEG or other brain imaging functional state and/or anatomical data (such as magnetoencephalography (MEG), quantitative MEG (QMEG), fMRI, CAT scan, PET, functional PET, X-ray, etc.), time change/time series, weighted factor, principal component, regional ensemble and/or artificial intelligence analysis. Utilization of such methods may also be applied to enhance individual statement verification and/or lie detection. In addition, such methods can be used to identify physiological state, pathophysiological state, including disease diagnosis, disease progression and/or remission, and other health and/or disease states and changes of interest.

Abstract: A method for treating a mammal with a demyelinating disease associated with an immunological disorder comprising administering methylcobalamin or cyanocobalamin.

Abstract: A method for treating neurological dysfunctions associated with AIDS or ARC comprising the administration of methylcobalamin, alone or in combination with methionine. Substantial increases in the number of T4+ T-lymphocytes, T8+ T-lymphocytes, or the ratio of T4+ to T8+ T-lymphocytes is also observed with this treatment.